Titan Pharmaceuticals Inc (NASDAQ:TTNP)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TTNP

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TTNP

  • Market Cap$24.660m
  • SymbolNASDAQ:TTNP
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS8883146065

Company Profile

Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides an efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development of pharmaceutical products.

Latest TTNP news

Currently there for this company. Visit our news hub for other news .